A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B

MLA

Janett Fischer, et al. “A STAT4 Variant Increases Liver Fibrosis Risk in Caucasian Patients with Chronic Hepatitis B.” Alimentary Pharmacology & Therapeutics, vol. 48, July 2018, pp. 564–73. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e5e7da088dfa094bb213bd5b9bc25048&authtype=sso&custid=ns315887.

APA

Janett Fischer, Ali Bayoumi, Jacob George, Salvatore Petta, Rosanna Santoro, Mayada Metwally, D.J. Leeming, Alessandro Loglio, R. El Sharkawy, Mohammed Eslam, Mark W. Douglas, Anis Khan, Pietro Lampertico, Willem P. Brouwer, A. Smedile, Christopher Liddle, Alessandra Mangia, Maria Lorena Abate, Andre Boonstra, … Thomas Berg. (2018). A STAT4 variant increases liver fibrosis risk in Caucasian patients with chronic hepatitis B. Alimentary Pharmacology & Therapeutics, 48, 564–573.

Chicago

Janett Fischer, Ali Bayoumi, Jacob George, Salvatore Petta, Rosanna Santoro, Mayada Metwally, D.J. Leeming, et al. 2018. “A STAT4 Variant Increases Liver Fibrosis Risk in Caucasian Patients with Chronic Hepatitis B.” Alimentary Pharmacology & Therapeutics 48 (July): 564–73. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....e5e7da088dfa094bb213bd5b9bc25048&authtype=sso&custid=ns315887.